ROPES WEALTH ADVISORS LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROPES WEALTH ADVISORS LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2021$263,000
-8.4%
9940.0%0.05%0.0%
Q3 2021$287,000
+28.1%
994
-15.0%
0.05%
+31.4%
Q4 2020$224,000
+21.7%
1,170
-6.3%
0.04%
-2.8%
Q3 2020$184,000
+10.2%
1,249
-7.5%
0.04%
+5.9%
Q2 2020$167,000
+28.5%
1,3500.0%0.03%
+3.0%
Q1 2020$130,000
+4.0%
1,3500.0%0.03%
+22.2%
Q4 2019$125,000
+20.2%
1,3500.0%0.03%
+22.7%
Q3 2019$104,000
-10.3%
1,3500.0%0.02%
-8.3%
Q2 2019$116,0001,3500.02%
Other shareholders
REPLIGEN CORP shareholders Q4 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders